Extension Of Deadlines By FDA Was Valid, Deeming Rule Plaintiffs Say
WASHINGTON, D.C. — In an Aug. 8 amended complaint, plaintiffs challenging the U.S. Food and Drug Administration’s “Deeming Rule” added a new count seeking a declaration that the FDA’s subsequent 2017...To view the full article, register now.
Already a subscriber? Click here to view full article